Isolation and comparative analysis of potential stem/progenitor cells from different regions of human umbilical cord

Stem Cell Research

Volumn 16, Issue 3, 2016, Pages 696-711

  Beeravolu, Naimisha ^a   Khan, Irfan ^a,b   McKee, Christina ^a   Dinda, Sumi ^a   Thibodeau, Bryan ^c   Wilson, George ^a,c   Perez Cruet, Mick ^a,c   Bahado Singh, Ray ^c   Chaudhry, G Rasul ^a  

^a OAKLAND UNIVERSITY   (United States)

^b UNIVERSITY OF KARACHI   (Pakistan)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Differentiation; Peri natal stem progenitor cells; Placenta; Proliferation; Umbilical cord

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD44V ANTIGEN; ENDOGLIN; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; LEUKOCYTE ANTIGEN; LIN-28 PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; UMBILICAL CORD; WHARTON JELLY; CELL CULTURE; CELL LINEAGE; CELL PROLIFERATION; CYTOLOGY; IMMUNOPHENOTYPING; METABOLISM;

ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; IMMUNOPHENOTYPING; NANOG HOMEOBOX PROTEIN; OCTAMER TRANSCRIPTION FACTOR-3; RNA-BINDING PROTEINS; STEM CELLS; UMBILICAL CORD; WHARTON JELLY;

EID: 84963973712     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2016.04.010     Document Type: Article

References (58)

1. Adams P.D., Jasper H., Rudolph K.L. Aging-induced stem cell mutations as drivers for disease and cancer. Cell Stem Cell 2015, 16:601-612.
2. Ambrosini G., Khanin R., Carvajal R.D., Schwartz G.K. Overexpression of DDX43 mediates MEK inhibitor resistance through RAS upregulation in uveal melanoma cells. Mol. Cancer Ther. 2014, 13:2073-2080.
3. Baksh D., Yao R., RS T. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
4. Bianco P., Robey P.G. Skeletal stem cells. Development 2015, 142:1023-1027.
5. Burkhalter M.D., Rudolph K.L., Sperka T. Genome instability of ageing stem cells-induction and defence mechanisms. Ageing Res. Rev. 2015, 23:29-36.
6. Campbell D.D., Pei M. Surface markers for chondrogenic determination: a highlight of synovium-derived stem cells. Cells 2012, 1:1107-1120.
7. Cao J. The functional role of long non-coding RNAs and epigenetics. Cao Biological Procedures Online 2014, 16.
8. Carpenter M.K., Fau R.E., Rao M.S., Rao M.S. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 2003, 5:79-88.
9. Catacchio I., Fau B.S., Reale A., Fau R.A., De Luisi A., Fau D.L.A., Racanelli V., Fau R.V., Vacca A., Fau V.A., Ria R., Ria R. Evidence for bone marrow adult stem cell plasticity: properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation. Stem Cells Int. 2013, 2013.
10. Chen H., Zhang N., Li T., Guo J., Wang Z., Yang M., Gao L. Human umbilical cord Wharton's jelly stem cells: immune property genes assay and effect of transplantation on the immune cells of heart failure patients. Cell. Immunol. 2012, 276:83-90.
11. Cheng H., Qiu L., Ma J., Zhang H., Cheng M., Li W., Zhao X., Liu K. Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts. Mol. Biol. Rep. 2011, 38:5161-5168.
12. Cho J.S., Park J.H., Kang J.H., Kim S.E., Park I.H., Lee H.M. Isolation and characterization of multipotent mesenchymal stem cells in nasal polyps. Exp. Biol. Med. (Maywood) 2015, 240:185-193.
13. Maria Teresa Conconi, Rosa Di Liddo, Mara Tommasini, Chiara Calore and, and Parnigotto, P.P. (2011). Phenotype and differentiation potential of stem populations obtained from various zones of human umbilical cord-an overview. Open Tissue Eng. Regen. Med. J. 4, 6-20.
14. Dharmavaram R.M., Fau H.A., Jimenez S.A., Jimenez S.A. Characterization of human chondrocyte and fibroblast type XII collagen cDNAs. Matrix Biol. 1998, 16:343-348.
15. Ding D.C., Chang Y.H., Shyu W.C., Lin S.Z. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015, 24:339-347.
16. D'Ippolito G., Schiller P.C., Ricordi C., BA R., Howard G.A. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J. Bone Miner. Res. 1999, 14:1115-1122.
17. Dominici M., Fau L.B.K., Mueller I., Fau M.I., Slaper-Cortenbach I., Fau S.-C.I., Marini F., Fau M.F., Krause D., Fau K.D., Deans R., Fau D.R., Keating A., Fau K.A., Prockop D., Fau P.D., Horwitz E., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
18. Durnaoglu S., Genc S., Genc K. Patient-specific pluripotent stem cells in neurological diseases. Stem Cells Int. 2011, 2011:212487.
19. Ennis J., Fau G.C., Le Blanc K., Fau L.B.K., Davies J.E., Davies J.E. In vitro immunologic properties of human umbilical cord perivascular cells. Cytotherapy 2008, 10:174-181.
20. Erices A., Conget P., Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 2000, 109:235-242.
21. Escacena N., Quesada-Hernandez E., Capilla-Gonzalez V., Soria B., Hmadcha A. Bottlenecks in the efficient use of advanced therapy medicinal products based on mesenchymal stromal cells. Stem Cells Int. 2015, 2015.
22. Fei X., Fau J.S., Zhang S., Fau Z.S., Li Y., Fau L.Y., Ge J., Fau G.J., He B., Fau H.B., Goldstein S., Fau G.S., Ruiz G., Ruiz G. Isolation, culture, and identification of amniotic fluid-derived mesenchymal stem cells. Cell Biochem. Biophys. 2013, 67:689-694.
23. Fischbach G.D., Fischbach R.L. Stem cells: science, policy, and ethics. J. Clin. Investig. 2004, 114:1364-1370.
24. Goldring C.E., Duffy P.A., Benvenisty N., Andrews P.W., Ben-David U., Eakins R., French N., Hanley N.A., Kelly L., Kitteringham N.R., et al. Assessing the safety of stem cell therapeutics. Cell Stem Cell 2011, 8:618-628.
25. Gonzalez R., Griparic L., Umana M., Burgee K., Vargas V., Nasrallah R., Silva F., Patel A. An efficient approach to isolation and characterization of pre- and postnatal umbilical cord lining stem cells for clinical applications. Cell Transplant. 2010, 19:1439-1449.
26. Goodwin H.S., Bicknese A.R., Chien S.N., Bogucki B.D., Oliver D.A., Quinn C.O., Wall D.A. Multilineage differentiation activity by cells isolated from umbilical cord blood-expression of bone, fat, and neural markers. Biol. Blood Marrow Transplant. 2001, 7:581-588.
27. Gregory K.E., Fau K.D., Tufa S.F., Fau T.S., Lunstrum G.P., Fau L.G., Morris N.P., Morris N.P. Developmental distribution of collagen type XII in cartilage: association with articular cartilage and the growth plate. J. Bone Miner. Res. 2001, 16:2005-2016.
28. Habip Akbulut G.C., Aktan T.M., Duman S. Expression of mesenchymal stem cell markers of human adipose tissue surrounding the vas deferens. Biomed. Res. 2012, 23:166-169.
29. Han Y.F., Fau T.R., Sun T.-J., Fau S.T., Chai J.-K., Fau C.J., Xu G., Fau X.G., Liu J., Liu J. Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods. Cytotechnology 2013, 65:819-827.
30. Hass R., Kasper C., Bohm S., Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell. Commun. Signal 2011, 9.
31. Hendijani, F., Sadeghi-Aliabadi H - and Haghjooy Javanmard, S. (2014). Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix. Cell Tissue Bank. 15, 555-565.
32. Hoffman L.M., Carpenter M.K. Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 2005, 23:699-708.
33. Itskovitz-Eldor M.A.a.J. Derivation and spontaneous differentiation of human embryonic stem cells. J. Anat. 2002, 200:225-232.
34. Jiang T., Liu W., Lv X., Sun H., Zhang L., Liu Y., Zhang W.J., Cao Y., Zhou G. Potent in vitro chondrogenesis of CD105 enriched human adipose-derived stem cells. Biomaterials 2010, 31:3564-3571.
35. Kadivar M., Khatami S., Mortazavi Y., Shokrgozar M.A., Taghikhani M., Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2006, 340:639-647.
36. Kim Y.S., Lee H.J., Yeo J.E., Kim Y.I., Choi Y.J., Koh Y.G. Isolation and characterization of human mesenchymal stem cells derived from synovial fluid in patients with osteochondral lesion of the talus. Am. J. Sports Med. 2015, 43:399-406.
37. Lee Y.S., Fau L.J., Park H.-Y., Fau P.H., Lim Y.-S., Fau L.Y., Lee J.-C., Fau L.J., Wang S.-G., Fau W.S., Lee B.-J., Lee B.J. Isolation of mesenchymal stromal cells (MSCs) from human adenoid tissue. Cell. Physiol. Biochem. 2013, 31:513-524.
38. Lin G., Liu G., Banie L., Wang G., Ning H., Lue T.F., Lin C.S. Tissue distribution of mesenchymal stem cell marker Stro-1. Stem Cells Dev. 2011, 20:1747-1752.
39. Mennan C., Wright K., Bhattacharjee A., Balain B., Richardson J., Roberts S. Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord. Biomed. Res. Int. 2013, 2013.
40. Narcisi R., Cleary M.a.A., Brama P.A.J., Hoogduijn M.J., Turysurz N., Derk ten Berge A.G.J.V.M.V.O. The functional role of long non-coding RNAs and epigenetics. Stem Cell Reports 2015, 4:459-472.
41. Nekanti U., Rao V.B., Bahirvani A.G., Jan M., Totey S., Ta M. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev. 2010, 19:117-130.
42. Odabas S., Fau E.A., Elcin Y.M., Elcin Y.M. Isolation and characterization of mesenchymal stem cells. Methods Mol. Biol. 2014, 1109:47-63.
43. Oh J., Lee Y.D., Wagers A.J. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat. Med. 2014, 20:870-880.
44. Okolicsanyi RK, Camilleri, E., Oikari, LE, Yu C, Cool SM, Van Wijnen AJ, Griffiths LR, Haupt LM. (2015). Human mesenchymal stem cells retain multilineage differentiation capacity including neural marker expression after extended in vitro expansion. PLoS One 10.
45. Osborne J., Hu C., Hawley C., Underwood L.J., O'Brien T.J., Baker V.V. Expression of HOXD10 gene in normal endometrium and endometrial adenocarcinoma. J. Soc. Gynecol. Investig. 1998, 5:277-280.
46. Robey P.G., Kuznetsov S.A., Riminucci M., Bianco P. Bone marrow stromal cell assays: in vitro and in vivo. Methods Mol. Biol. 2014, 1130:279-293.
47. Romanov Y.A., Svintsitskaya V.A., Smirnov V.N. Searching for alternative sources of postnatal human mesenchymal stem cells-candidate MSC-like cells from umbilical cord. Stem Cells 2003, 21:105-110.
48. Rosada C., Justesen J., Melsvik D., Ebbesen P., Kassem M. The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcif. Tissue Int. 2003, 72:135-142.
49. Sarugaser R., Lickorish D., Baksh D., Hosseini M.M., Davies J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005, 23:220-229.
50. Sivasubramaniyan K., Harichandan A., Schumann S., Sobiesiak M., Lengerke C., Maurer A., Kalbacher H., Buhring H.J. Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against sushi domain containing 2. Stem Cells Dev. 2013, 22:1944-1954.
51. Steigman S.A., Fauza D.O. Isolation of mesenchymal stem cells from amniotic fluid and placenta. Curr. Protoc. Stem Cell. Biol. 2007, Chapter 1. (Unit 1E 2).
52. Taylor D.W., Fau A.N., Parreno J., Fau P.J., Lunstrum G.P., Fau L.G., Gross A.E., Fau G.A., Diamandis E.P., Fau D.E., Kandel R.A., Kandel R.A. Collagen type XII and versican are present in the early stages of cartilage tissue formation by both dedifferentiating passaged and primary chondrocytes. Tissue Eng. A 2015, 21:683-693.
53. Walters J.R., Howard A., Rumble H.E., Prathalingam S.R., Shaw-Smith C.J., Legon S. Differences in expression of homeobox transcription factors in proximal and distal human small intestine. Gastroenterology 1997, 113:472-477.
54. Weiss M.L., Medicetty S., Bledsoe A.R., Rachakatla R.S., Choi M., Merchav S., Luo Y., Rao M.S., Velagaleti G., Troyer D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24:781-792.
55. Wouters G., Fau G.S., Mesoraca A., Fau M.A., Bizzoco D., Fau B.D., Mobili L., Fau M.L., Cignini P., Fau C.P., Giorlandino C., Giorlandino C. Isolation of amniotic fluid-derived mesenchymal stem cells. J. Prenat. Med. 2007, 1:39-40.
56. Yuan L., Xiao Y., Zhou Q., Yuan D., Wu B., Chen G., Zhou J. Proteomic analysis reveals that MAEL, a component of nuage, interacts with stress granule proteins in cancer cells. Oncol. Rep. 2014, 31:342-350.
57. Zaim M., Karaman S., Cetin G., Isik S. Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann. Hematol. 2012, 91:1175-1186.
58. Zhai J.M., Sun S.J., Wang W., Zeng C. Expression of annexin A3 in gastric cancer and its correlation with proliferation and apoptosis. Asian Pac. J Cancer Prev 2014, 15:3001-3004.